A Pre-Screening Study to Conduct a Future Clinical Study in Participants Allergic to Common Ragweed (Ambrosia artemisiifolia)

If you are interested in participating in this clinical trial, please fill out the contact form below to speak to one of our Research Coordinators to find out if this study is right for you.

A Pre-Screening Study to Conduct a Future Clinical Study in Participants Allergic to Common Ragweed (Ambrosia artemisiifolia)

This pre-screening study will identify and characterize a patient population with a history of ragweed-induced rhinoconjunctivitis who may benefit from treatment and potentially be included in future interventional studies.

To be eligible for this study, you must be:

  • 18 years of age or older

  • Allergic to ragweed pollen

  • Not currently on allergy shots

This is not a complete list of eligibility criteria. The study doctor will review the full entry criteria for this study with you.


Please complete the form below if you are interested in learning more about this study and would like to schedule a phone call with one of our coordinators to discuss further.